MRK · NYQ S&P 500

Merck & Co., Inc.

Healthcare · Drug Manufacturers - General

$148.05 −$0.71 (−0.48%) today

Closing price on Nov 10, 2026 · Source: Yahoo Finance

Consensus of 28 analysts

Buy

Median price target $165.00 +11.4%

Open: $148.40
Day range: 145.58 – $149.19
52-week range: 87.26 – $156.92
Volume: 5,363,569
Market cap: $364,980M
P/E (TTM): 149.5x
EPS (TTM): $0.99
EPS est. 2026: $2.78
P/E est. 2026: 53.3x
Dividend yield: 2.3%
Beta: 0.12
Payout: 343%

Merck & financials

Q3 2026 results, quarter ended Sep 30, 2026

Metric	Q3 2026	1-year change
Total revenue	$18,085M	+4.7%
Net income	$5,065M	−12.4%
Earnings per share	$2.04	−12.1%
Net margin	28.0%	−5.5 pp
Free cash flow	$5,518M	−19.3%
Debt / equity	1.20	+50.1%

Revenue and net income ($M)

Total revenueNet income

Quarter	Total revenue	Net income
Q3 2025	$17,276M	$5,785M
Q4 2025	$16,400M	$2,963M
Q1 2026	$16,286M	−$4,240M
Q2 2026	$16,607M	−$1,335M
Q3 2026	$18,085M	$5,065M

Merck & earnings per share (EPS)

Consensus estimates

Period	EPS est.	1-year change
Current quarterQ4 2026 · Analysts: 19	$1.7581.70 – 1.96	−13.8%$2.040
Next quarterQ1 2027 · Analysts: 9	$2.1291.97 – 2.27	+266.3%−$1.280
Current year2026 · Analysts: 26	$2.7802.50 – 2.99	−69.0%$8.980
Next year2027 · Analysts: 25	$8.9818.45 – 9.75	+223.1%$2.780

Forward P/E: 53.3x (2026) and 16.5x (2027) at the current price.

Actual and estimated EPS ($)

Actual EPSEstimated EPS

Quarter	Actual EPS	Estimated EPS
Q3 2025	$2.320	—
Q4 2025	$2.040	$2.011
Q1 2026	−$1.280	−$1.474
Q2 2026	−$0.130	−$0.257
Q3 2026	$2.490	$2.082
Q4 2026	—	$1.758
Q1 2027	—	$2.129

Year	Actual EPS	Estimated EPS
2022	$5.710	—
2023	$0.140	—
2024	$6.740	—
2025	$7.280	—
2026	—	$2.780
2027	—	$8.981

EPS trend

Quarter	EPS	YoY change
Q1 2027Estimated	$2.129	n/s
Q4 2026Estimated	$1.758	−13.8%
Q3 2026	$2.490est. $2.082 · surprise +19.6%	+7.3%
Q2 2026	−$0.130est. −$0.257 · surprise +49.4%	n/a
Q1 2026	−$1.280est. −$1.474 · surprise +13.2%	n/a
Q4 2025	$2.040est. $2.011 · surprise +1.5%	n/a
Q3 2025	$2.320	n/a

Year	EPS	Annual change
2027Estimated	$8.981	+223.1%
2026Estimated	$2.780	−61.8%
2025	$7.280	+8.0%
2024	$6.740	+4,714.3%
2023	$0.140	−97.5%
2022	$5.710	n/a

Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.

Merck & dividend

Yield and payments

Dividend yield (TTM)	2.3%
Forward yield (next 12m)	2.3%
Dividend per share (TTM)	$3.36
Forward dividend (next 12m)	$3.40
Payout (TTM)	343%
Last dividend	$0.85Sep 15, 2026
Next ex-dividend date	n/a

Dividend per share by year ($)

PaidEstimated

Year	Dividend per share
2019	$2.16
2020	$2.37
2021	$2.61
2022	$2.80
2023	$2.96
2024	$3.12
2025	$3.28
est. 12m	$3.40

Merck & forecasts

28 analyst ratings

Buy68% Hold32% Sell0%

Consensus: Buy · 19 buy, 9 hold, 0 sell

1-year price forecast

Share price Price target (high, median, low)

12-month price targets
Target	Price	Upside
High	$186.00	+25.6%
Median	$165.00	+11.4%
Low	$105.00	−29.1%

Monthly close (last 12 months)
Date	Close
Nov 28, 2025	$104.83
Dec 31, 2025	$105.26
Jan 30, 2026	$110.27
Feb 27, 2026	$123.82
Mar 31, 2026	$120.29
Apr 30, 2026	$109.18
May 29, 2026	$118.72
Jun 30, 2026	$128.50
Jul 31, 2026	$130.20
Aug 31, 2026	$147.76
Sep 30, 2026	$145.31
Oct 30, 2026	$149.52
Nov 10, 2026	$148.05

Merck & peers

Ticker	Company	Market cap ($M)	P/E	Price ($)	1-day change	52-week range
MRK	Merck &	364,980	149.5x	148.05	−0.48%	87.26156.92
LLY	Lilly	1,275,805	46.5x	1,432.29	+1.44%	850.511,453.00
JNJ	Johnson & Johnson	675,925	42.6x	280.78	−0.47%	189.05283.25
ABBV	AbbVie	519,485	50.5x	293.89	+0.20%	190.75302.93
AMGN	Amgen	251,648	27.0x	465.23	0.00%	312.39483.99
GILD	Gilead Sciences	211,937	n/a	170.87	+0.92%	116.88176.58